Mirion Technologies, Inc. (MIR) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.08 per share a year ago.
Mirion Technologies is rated a buy, supported by strong nuclear power demand and a robust, recurring revenue model. The Paragon acquisition doubles MIR's SMR exposure, enhances its product portfolio, and strengthens its position in next-generation nuclear technology. MIR targets 30% EBITDA margins by 2028, driven by operating leverage, business mix shift, and operational restructuring.
Mirion Technologies (MIR) could produce exceptional returns because of its solid growth attributes.
Mirion Technologies (MIR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
MIR tops Q2 estimates, lifts 2025 outlook, and rides AI-fueled nuclear momentum with strong digital upgrades.
Mirion Technologies, Inc. (MIR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Mirion Technologies, Inc. (NYSE:MIR ) Q2 2025 Earnings Conference Call August 1, 2025 10:00 AM ET Company Participants Brian Schopfer - Chief Financial Officer Eric Linn - Corporate Participant Thomas D. Logan - Founder, Medical Group President, CEO & Chairman Conference Call Participants Andrew Alec Kaplowitz - Citigroup Inc., Research Division Christopher Paul Moore - CJS Securities, Inc. Joseph Alfred Ritchie - Goldman Sachs Group, Inc., Research Division Robert W.
Mirion Technologies, Inc. (MIR) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.1 per share a year ago.
MIR surges over 100% in a year as digital innovation, nuclear demand, and strong 2025 guidance set it apart from BWXT.
Mirion Technologies (MIR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
MIR's Q2 results may ride on nuclear demand and medical growth, but trade risks could be a dampener.
MIR is looking to digitize nuclear systems to boost safety, precision and remote monitoring.